Advertisement

Topics

Fresenius invests in BioIntelliSense for new remote health monitoring platform

10:39 EDT 10 Jul 2019 | Compelo Medical Devices

US-based BioIntelliSense is engaged in developing a medical grade data services platform for continuous health monitoring, predictive analytics and algorithmic clinical insights. In addition, BioIntelliSense’s data-driven platform is

The post Fresenius invests in BioIntelliSense for new remote health monitoring platform appeared first on NS Medical Devices.

Original Article: Fresenius invests in BioIntelliSense for new remote health monitoring platform

NEXT ARTICLE

More From BioPortfolio on "Fresenius invests in BioIntelliSense for new remote health monitoring platform"

Advertisement
Quick Search
Advertisement
Advertisement